Only through targeted sequencing of regulatory regions in OTC was a variant confirmed, highlighting the importance of evaluating noncoding regions in patients with suspected OTC deficiency when initial attempts at sequencing fail to identify any variants [6]. The gene discussed is OTC; the disease is ornithine carbamoyltransferase deficiency.